Nanophotosensitizers toward advanced photodynamic therapy of Cancer

Chang Keun Lim, Jeongyun Heo, Seunghoon Shin, Keunsoo Jeong, Young Hun Seo, Woo Dong Jang, Chong Rae Park, Soo Young Park, Sehoon Kim, Ick Chan Kwon

Research output: Contribution to journalArticle

141 Citations (Scopus)

Abstract

Photodynamic therapy (PDT) is a non-invasive treatment modality for selective destruction of cancer and other diseases and involves the colocalization of light, oxygen, and a photosensitizer (PS) to achieve photocytotoxicity. Although this therapeutic method has considerably improved the quality of life and life expectancy of cancer patients, further advances in selectivity and therapeutic efficacy are required to overcome numerous side effects related to classical PDT. The application of nanoscale photosensitizers (NPSs) comprising molecular PSs and nanocarriers with or without other biological/photophysical functions is a promising approach for improving PDT. In this review, we focus on four nanomedical approaches for advanced PDT: (1) nanocarriers for targeted delivery of PS, (2) introduction of active targeting moieties for disease-specific PDT, (3) stimulus-responsive NPSs for selective PDT, and (4) photophysical improvements in NPS for enhanced PDT efficacy.

Original languageEnglish
Pages (from-to)176-187
Number of pages12
JournalCancer Letters
Volume334
Issue number2
DOIs
Publication statusPublished - 2013 Jul 1
Externally publishedYes

Fingerprint

Photodynamic therapy
Photochemotherapy
Photosensitizing Agents
Neoplasms
Life Expectancy
Therapeutics
Quality of Life
Oxygen
Light

Keywords

  • Nanomedicine
  • Nanotherapeutics
  • Photodynamic therapy
  • Photosensitizer

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Lim, C. K., Heo, J., Shin, S., Jeong, K., Seo, Y. H., Jang, W. D., ... Kwon, I. C. (2013). Nanophotosensitizers toward advanced photodynamic therapy of Cancer. Cancer Letters, 334(2), 176-187. https://doi.org/10.1016/j.canlet.2012.09.012

Nanophotosensitizers toward advanced photodynamic therapy of Cancer. / Lim, Chang Keun; Heo, Jeongyun; Shin, Seunghoon; Jeong, Keunsoo; Seo, Young Hun; Jang, Woo Dong; Park, Chong Rae; Park, Soo Young; Kim, Sehoon; Kwon, Ick Chan.

In: Cancer Letters, Vol. 334, No. 2, 01.07.2013, p. 176-187.

Research output: Contribution to journalArticle

Lim, CK, Heo, J, Shin, S, Jeong, K, Seo, YH, Jang, WD, Park, CR, Park, SY, Kim, S & Kwon, IC 2013, 'Nanophotosensitizers toward advanced photodynamic therapy of Cancer', Cancer Letters, vol. 334, no. 2, pp. 176-187. https://doi.org/10.1016/j.canlet.2012.09.012
Lim CK, Heo J, Shin S, Jeong K, Seo YH, Jang WD et al. Nanophotosensitizers toward advanced photodynamic therapy of Cancer. Cancer Letters. 2013 Jul 1;334(2):176-187. https://doi.org/10.1016/j.canlet.2012.09.012
Lim, Chang Keun ; Heo, Jeongyun ; Shin, Seunghoon ; Jeong, Keunsoo ; Seo, Young Hun ; Jang, Woo Dong ; Park, Chong Rae ; Park, Soo Young ; Kim, Sehoon ; Kwon, Ick Chan. / Nanophotosensitizers toward advanced photodynamic therapy of Cancer. In: Cancer Letters. 2013 ; Vol. 334, No. 2. pp. 176-187.
@article{34ac86ccc2f049c1a4a82c2badc46760,
title = "Nanophotosensitizers toward advanced photodynamic therapy of Cancer",
abstract = "Photodynamic therapy (PDT) is a non-invasive treatment modality for selective destruction of cancer and other diseases and involves the colocalization of light, oxygen, and a photosensitizer (PS) to achieve photocytotoxicity. Although this therapeutic method has considerably improved the quality of life and life expectancy of cancer patients, further advances in selectivity and therapeutic efficacy are required to overcome numerous side effects related to classical PDT. The application of nanoscale photosensitizers (NPSs) comprising molecular PSs and nanocarriers with or without other biological/photophysical functions is a promising approach for improving PDT. In this review, we focus on four nanomedical approaches for advanced PDT: (1) nanocarriers for targeted delivery of PS, (2) introduction of active targeting moieties for disease-specific PDT, (3) stimulus-responsive NPSs for selective PDT, and (4) photophysical improvements in NPS for enhanced PDT efficacy.",
keywords = "Nanomedicine, Nanotherapeutics, Photodynamic therapy, Photosensitizer",
author = "Lim, {Chang Keun} and Jeongyun Heo and Seunghoon Shin and Keunsoo Jeong and Seo, {Young Hun} and Jang, {Woo Dong} and Park, {Chong Rae} and Park, {Soo Young} and Sehoon Kim and Kwon, {Ick Chan}",
year = "2013",
month = "7",
day = "1",
doi = "10.1016/j.canlet.2012.09.012",
language = "English",
volume = "334",
pages = "176--187",
journal = "The BMJ",
issn = "0730-6512",
publisher = "Kluwer Academic Publishers",
number = "2",

}

TY - JOUR

T1 - Nanophotosensitizers toward advanced photodynamic therapy of Cancer

AU - Lim, Chang Keun

AU - Heo, Jeongyun

AU - Shin, Seunghoon

AU - Jeong, Keunsoo

AU - Seo, Young Hun

AU - Jang, Woo Dong

AU - Park, Chong Rae

AU - Park, Soo Young

AU - Kim, Sehoon

AU - Kwon, Ick Chan

PY - 2013/7/1

Y1 - 2013/7/1

N2 - Photodynamic therapy (PDT) is a non-invasive treatment modality for selective destruction of cancer and other diseases and involves the colocalization of light, oxygen, and a photosensitizer (PS) to achieve photocytotoxicity. Although this therapeutic method has considerably improved the quality of life and life expectancy of cancer patients, further advances in selectivity and therapeutic efficacy are required to overcome numerous side effects related to classical PDT. The application of nanoscale photosensitizers (NPSs) comprising molecular PSs and nanocarriers with or without other biological/photophysical functions is a promising approach for improving PDT. In this review, we focus on four nanomedical approaches for advanced PDT: (1) nanocarriers for targeted delivery of PS, (2) introduction of active targeting moieties for disease-specific PDT, (3) stimulus-responsive NPSs for selective PDT, and (4) photophysical improvements in NPS for enhanced PDT efficacy.

AB - Photodynamic therapy (PDT) is a non-invasive treatment modality for selective destruction of cancer and other diseases and involves the colocalization of light, oxygen, and a photosensitizer (PS) to achieve photocytotoxicity. Although this therapeutic method has considerably improved the quality of life and life expectancy of cancer patients, further advances in selectivity and therapeutic efficacy are required to overcome numerous side effects related to classical PDT. The application of nanoscale photosensitizers (NPSs) comprising molecular PSs and nanocarriers with or without other biological/photophysical functions is a promising approach for improving PDT. In this review, we focus on four nanomedical approaches for advanced PDT: (1) nanocarriers for targeted delivery of PS, (2) introduction of active targeting moieties for disease-specific PDT, (3) stimulus-responsive NPSs for selective PDT, and (4) photophysical improvements in NPS for enhanced PDT efficacy.

KW - Nanomedicine

KW - Nanotherapeutics

KW - Photodynamic therapy

KW - Photosensitizer

UR - http://www.scopus.com/inward/record.url?scp=84878240072&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84878240072&partnerID=8YFLogxK

U2 - 10.1016/j.canlet.2012.09.012

DO - 10.1016/j.canlet.2012.09.012

M3 - Article

VL - 334

SP - 176

EP - 187

JO - The BMJ

JF - The BMJ

SN - 0730-6512

IS - 2

ER -